Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals

Arthritis Research and Therapy

Volumn 14, Issue 3, 2012, Pages

  Mercer, Emileigh ^a   Rekedal, Laura ^a   Garg, Rajesh ^a   Lu, Bing ^a   Massarotti, Elena M ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CELL SECRETION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT ESTIMATED INSULIN RESISTANCE; HUMAN; INFORMATION PROCESSING; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MALE; MATSUDA INSULIN SENSITIVITY INDEX; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RATING SCALE; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; TREND STUDY; CLINICAL TRIAL; MIDDLE AGED;

ANTIRHEUMATIC AGENTS; BODY MASS INDEX; FEMALE; HUMANS; HYDROXYCHLOROQUINE; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY;

EID: 84861888850     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3868     Document Type: Article

References (31)

1. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#, 11762933.
2. Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005, 64:1595-1601. 10.1136/ard.2004.034777, 1755282, 15843450.
3. Ramsey-Goldman R, Manzi S. Association of osteoporosis and cardiovascular disease in women with systemic lupus erythematosus. Arthritis Rheum 2001, 44:2338-2341. 10.1002/1529-0131(200110)44:10<2338::AID-ART396>3.0.CO;2-V, 11665974.
4. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307. 10.1161/01.CIR.0000054612.26458.B2, 12628952.
5. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005, 111:3481-3488. 10.1161/CIRCULATIONAHA.105.537878, 15983262.
6. Nasr G, Sliem H. Silent myocardial ischemia in prediabetics in relation to insulin resistance. J Cardiovasc Dis Res 2010, 1:116-121. 10.4103/0975-3583.70903, 2982198, 21187864.
7. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214. 10.2337/diabetes.52.5.1210, 12716754.
8. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
9. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008, 196:756-763. 10.1016/j.atherosclerosis.2007.01.004, 17266963.
10. El Magadmi M, Ahmad Y, Turkie W, Yates AP, Sheikh N, Bernstein RM, Durrington PN, Laing I, Bruce IN. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 2006, 33:50-56.
11. Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 2005, 64:765-766. 10.1136/ard.2004.026534, 1755470, 15458960.
12. Rosenvinge A, Krogh-Madsen R, Baslund B, Pedersen BK. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy. Scand J Rheumatol 2007, 36:91-96. 10.1080/03009740601179605, 17476613.
13. Tam LS, Tomlinson B, Chu TT, Li TK, Li EK. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 2007, 26:1495-1498. 10.1007/s10067-007-0539-8, 17237906.
14. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007, 356:1517-1526. 10.1056/NEJMoa065213, 17429083.
15. Gerstein HC, Thorpe KE, Taylor DW, Haynes RB. The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial. Diabetes Res Clin Pract 2002, 55:209-219. 10.1016/S0168-8227(01)00325-4, 11850097.
16. Quatraro A, Consoli G, Magno M, Caretta F, Nardozza A, Ceriello A, Giugliano D. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?. Ann Intern Med 1990, 112:678-681.
17. Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L, Manzi S, Wasko MC. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2010, 37:1136-1142. 10.3899/jrheum.090994, 20436082.
18. Wasko MC, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. Jama 2007, 298:187-193. 10.1001/jama.298.2.187, 17622600.
19. Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. Jama 2011, 305:2525-2531. 10.1001/jama.2011.878, 21693740.
20. Emami J, Gerstein HC, Pasutto FM, Jamali F. Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent. Can J Physiol Pharmacol 1999, 77:118-123. 10.1139/y98-146, 10535702.
21. Garcia-Webb P, Bonser AM. Insulin binding and degradation in isolated hepatocytes from streptozotocin injected rats. Biochem Biophys Res Commun 1985, 128:487-493. 10.1016/0006-291X(85)90073-7, 3888217.
22. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470. 10.2337/diacare.22.9.1462, 10480510.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
24. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
25. Chazova I, Almazov VA, Shlyakhto E. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes Obese Metab 2006, 8:456-465.
26. Miyazaki Y, Matsuda M, DeFronzo R. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care 2002, 25:517-523. 10.2337/diacare.25.3.517, 11874940.
27. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC, Horwitz RI. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke. Stroke 2003, 34:1431-1436. 10.1161/01.STR.0000071108.00234.0E, 12730556.
28. Glass LC, Cusi K, Berria R, Petz R, Cersosimo E, DeFronzo R, Gastaldelli A. Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with type 2 diabetes: a double tracer OGTT study. Clin Endocrinol 2010, 73:339-345.
29. Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA. Comparison of glargine insuline versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea. Diabetes Care 2006, 29:2371-2377. 10.2337/dc06-0564, 17065670.
30. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009, 145:379-382. 10.1001/archdermatol.2009.48, 2849106, 19380659.
31. Solomon DH, Love TJ, Canning C, Schneeweiss S. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010, 69:2114-2117. 10.1136/ard.2009.125476, 2991521, 20584807.